KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Exact Sciences (EXAS) over the last 6 years, with Q4 2025 value amounting to $406000.0.

  • Exact Sciences' Asset Writedowns and Impairment fell 9995.16% to $406000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $7.2 million, marking a year-over-year decrease of 9917.19%. This contributed to the annual value of $7.2 million for FY2025, which is 9917.19% down from last year.
  • Latest data reveals that Exact Sciences reported Asset Writedowns and Impairment of $406000.0 as of Q4 2025, which was down 9995.16% from $543000.0 recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Asset Writedowns and Impairment registered a high of $838.2 million during Q4 2024, and its lowest value of $69000.0 during Q1 2023.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $5.9 million (2022), whereas its average is $70.3 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first skyrocketed by 634347.83% in 2024, then plummeted by 9995.16% in 2025.
  • Over the past 5 years, Exact Sciences' Asset Writedowns and Impairment (Quarter) stood at $20.2 million in 2021, then crashed by 83.02% to $3.4 million in 2022, then tumbled by 83.92% to $552000.0 in 2023, then soared by 151741.3% to $838.2 million in 2024, then tumbled by 99.95% to $406000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $406000.0 for Q4 2025, versus $543000.0 for Q3 2025 and $6.3 million for Q1 2025.